Market research
SRT.F Sartorius Aktiengesellschaft
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 13B
- P/E ratio
- 64.1
- Analyst target
- 249.5278
- Dividend yield
- 0.4%
- Beta
- 1.47
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- DE0007165607
- Market cap
- 13B
- P/E ratio
- 64.1
- Analyst target
- 249.5278
- Dividend yield
- 0.4%
- Beta
- 1.47
About
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SRT.F discussion.
5 years, 5 months ago
Sartorius Aktiengesellschaft is currently in a long term uptrend where the price is trading 24.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.9.
Sartorius Aktiengesellschaft's total revenue rose by 39.2% to $656M since the same quarter in the previous year.
Its net income has increased by 117.7% to $77M since the same quarter in the previous year.
Finally, its free cash flow fell by 60.8% to $26M since the same quarter in the previous year.
Based on the above factors, Sartorius Aktiengesellschaft gets an overall score of 4/5.